Search

everythinglearnresearchcommunity

for

Search:↓

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Twist1 helps maintain important features of cells crucial for hair growth by working with Tcf4 and β-catenin.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

The document's content cannot be summarized because it is not accessible or understandable.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Teledermatology is crucial and effective for remote skin care in India.

Breast cancer patients need better psychological support to improve their quality of life.

New method effectively detects illegal hormones in anti-aging foods.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

The document's conclusion cannot be provided because the text is not in a processable format.

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Testosterone and finasteride improve body composition in men with spinal cord injury.

HairFortin may help reduce hair loss and promote regrowth.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.